nefiracetam has been researched along with glutamic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawajiri, S; Sakurai, T; Taniguchi, K; Yamasaki, T | 1 |
| Enikolopo, G; Enikolopov, G; Kondoh, T; Matuoka, T; Nishizaki, T; Nomura, T; Shiotani, T; Sumikawa, K; Watabe, S; Yoshii, M | 1 |
2 other study(ies) available for nefiracetam and glutamic acid
| Article | Year |
|---|---|
Nefiracetam enhances acetylcholine outflow from the frontal cortex: in vivo microdialysis study in the rat.
Topics: Acetylcholine; Animals; Calcium Channels; Data Interpretation, Statistical; Frontal Lobe; gamma-Aminobutyric Acid; Glutamic Acid; Male; Microdialysis; Physostigmine; Pyrrolidinones; Rats; Rats, Wistar; Scopolamine; Synaptic Transmission; Tetrodotoxin | 1994 |
The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors.
Topics: Animals; Cells, Cultured; Central Nervous System Agents; Denervation; Enzyme Inhibitors; Glutamic Acid; Hippocampus; Indoles; Maleimides; Presynaptic Terminals; Protein Kinase C; Pyrrolidinones; Rats; Receptors, Nicotinic; Synaptic Transmission | 2000 |